{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T02:37:57Z","timestamp":1774319877082,"version":"3.50.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2020,4,29]],"date-time":"2020-04-29T00:00:00Z","timestamp":1588118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,4,29]],"date-time":"2020-04-29T00:00:00Z","timestamp":1588118400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Chem Res"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1007\/s00044-020-02544-1","type":"journal-article","created":{"date-parts":[[2020,4,29]],"date-time":"2020-04-29T18:04:31Z","timestamp":1588183471000},"page":"1041-1057","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Oxygenated xanthones as P-glycoprotein modulators at the intestinal barrier: in vitro and docking studies"],"prefix":"10.1007","volume":"29","author":[{"given":"Vera","family":"Silva","sequence":"first","affiliation":[]},{"given":"Eva","family":"Gil-Martins","sequence":"additional","affiliation":[]},{"given":"Carolina","family":"Rocha-Pereira","sequence":"additional","affiliation":[]},{"given":"Agostinho","family":"Lemos","sequence":"additional","affiliation":[]},{"given":"Andreia","family":"Palmeira","sequence":"additional","affiliation":[]},{"given":"Ploenthip","family":"Puthongking","sequence":"additional","affiliation":[]},{"given":"Em\u00edlia","family":"Sousa","sequence":"additional","affiliation":[]},{"given":"Maria","family":"de Lourdes Bastos","sequence":"additional","affiliation":[]},{"given":"Fernando","family":"Remi\u00e3o","sequence":"additional","affiliation":[]},{"given":"Renata","family":"Silva","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2020,4,29]]},"reference":[{"issue":"1","key":"2544_CR1","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.toxlet.2014.06.031","volume":"229","author":"MD Arbo","year":"2014","unstructured":"Arbo MD, Silva R, Barbosa DJ, da Silva DD, Rossato LG, Bastos MdL, Carmo H (2014) Piperazine designer drugs induce toxicity in cardiomyoblast h9c2 cells through mitochondrial impairment. Toxicol Lett 229(1):178\u2013189","journal-title":"Toxicol Lett"},{"issue":"5","key":"2544_CR2","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/sj.leu.2400639","volume":"11","author":"J Asschert","year":"1997","unstructured":"Asschert J, de Vries E, van der Kolk D, Muller M, Vellenga E (1997) The combined effects of IL-3 and PSC 833 on daunorubicin- and mitoxantrone cytotoxicity in two growth factor-dependent leukemic cell lines. Leukemia 11(5):680\u2013686","journal-title":"Leukemia"},{"issue":"2","key":"2544_CR3","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1007\/s00204-013-1147-9","volume":"88","author":"DJ Barbosa","year":"2014","unstructured":"Barbosa DJ, Capela JP, Silva R, Ferreira LM, Branco PS, Fernandes E, Bastos ML, Carvalho F (2014) \u201cEcstasy\u201d-induced toxicity in SH-SY5Y differentiated cells: role of hyperthermia and metabolites. Arch Toxicol 88(2):515\u2013531","journal-title":"Arch Toxicol"},{"issue":"1","key":"2544_CR4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0887-2333(88)90030-6","volume":"2","author":"E Borenfreund","year":"1988","unstructured":"Borenfreund E, Babich H, Martin-Alguacil N (1988) Comparisons of two in vitro cytotoxicity assays\u2014the neutral red (NR) and tetrazolium MTT tests. Toxicol Vitr 2(1):1\u20136","journal-title":"Toxicol Vitr"},{"issue":"6","key":"2544_CR5","doi-asserted-by":"crossref","first-page":"3163","DOI":"10.1074\/jbc.271.6.3163","volume":"271","author":"MJ Borgnia","year":"1996","unstructured":"Borgnia MJ, Eytan GD, Assaraf YG (1996) Competition of hydrophobic peptides, cytotoxic drugs, and chemosensitizers on a common P-glycoprotein pharmacophore as revealed by its ATPase activity. J Biol Chem 271(6):3163\u20133171","journal-title":"J Biol Chem"},{"issue":"12","key":"2544_CR6","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1038\/sj.leu.2400511","volume":"11","author":"U Consoli","year":"1997","unstructured":"Consoli U, Van NT, Neamati N, Mahadevia R, Beran M, Zhao S, Andreeff M (1997) Cellular pharmacology of mitoxantrone in p-glycoprotein-positive and -negative human myeloid leukemic cell lines. Leukemia 11(12):2066\u20132074","journal-title":"Leukemia"},{"key":"2544_CR7","doi-asserted-by":"crossref","unstructured":"Cruz I, Puthongking P, Cravo S, Palmeira A, Cidade H, Pinto M and Sousa E (2017) Xanthone and flavone derivatives as dual agents with acetylcholinesterase inhibition and antioxidant activity as potential anti-Alzheimer agents. J Chem 2017:16 pages","DOI":"10.1155\/2017\/8587260"},{"issue":"4","key":"2544_CR8","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1002\/(SICI)1097-458X(199804)36:4<305::AID-OMR193>3.0.CO;2-N","volume":"36","author":"EG Fernandes","year":"1998","unstructured":"Fernandes EG, Silva AM, Cavaleiro JA, Silva FM, Fernanda M, Borges M, Pinto MM (1998) 1H and 13C NMR Spectroscopy of mono\u2010, di\u2010, tri\u2010and tetrasubstituted xanthones. Magn Reson Chem 36(4):305\u2013309","journal-title":"Magn Reson Chem"},{"issue":"6","key":"2544_CR9","first-page":"1010","volume":"14","author":"M Froimowitz","year":"1993","unstructured":"Froimowitz M (1993) HyperChem: a software package for computational chemistry and molecular modeling. Biotechniques 14(6):1010\u20131013","journal-title":"Biotechniques"},{"issue":"8","key":"2544_CR10","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.tips.2004.06.002","volume":"25","author":"MF Fromm","year":"2004","unstructured":"Fromm MF (2004) Importance of P-glycoprotein at blood-tissue barriers. Trends Pharm Sci 25(8):423\u2013429","journal-title":"Trends Pharm Sci"},{"key":"2544_CR11","doi-asserted-by":"crossref","first-page":"E600","DOI":"10.3390\/molecules22040600","volume":"22","author":"M Gameiro","year":"2017","unstructured":"Gameiro M, Silva R, Rocha-Pereira C, Carmo H, Carvalho F, Bastos ML, Remiao F (2017) Cellular models and in vitro assays for the screening of modulators of P-gp, MRP1 and BCRP. Molecules 22:E600","journal-title":"Molecules"},{"key":"2544_CR12","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.canlet.2019.01.014","volume":"446","author":"S Gomes","year":"2019","unstructured":"Gomes S, Raimundo L, Soares J, Loureiro JB, Leao M, Ramos H, Monteiro MN, Lemos A, Moreira J, Pinto M, Chlapek P, Veselska R, Sousa E, Saraiva L (2019) New inhibitor of the TAp73 interaction with MDM2 and mutant p53 with promising antitumor activity against neuroblastoma. Cancer Lett 446:90\u2013102","journal-title":"Cancer Lett"},{"issue":"8","key":"2544_CR13","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1007\/s00044-017-1893-y","volume":"26","author":"N Kumar","year":"2017","unstructured":"Kumar N, Goel N, Chand Yadav T, Pruthi V (2017) Quantum chemical, ADMET and molecular docking studies of ferulic acid amide derivatives with a novel anticancer drug target. Med Chem Res 26(8):1822\u20131834","journal-title":"Med Chem Res"},{"issue":"9","key":"2544_CR14","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1080\/07391102.2018.1481457","volume":"37","author":"N Kumar","year":"2019","unstructured":"Kumar N, Gupta S, Chand Yadav T, Pruthi V, Kumar Varadwaj P, Goel N (2019) Extrapolation of phenolic compounds as multi-target agents against cancer and inflammation. J Biomol Struct Dyn 37(9):2355\u20132369","journal-title":"J Biomol Struct Dyn"},{"issue":"10","key":"2544_CR15","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.3390\/molecules24101975","volume":"24","author":"A Lemos","year":"2019","unstructured":"Lemos A, Gomes AS, Loureiro JB, Brand\u00e3o P, Palmeira A, Pinto MMM, Saraiva L, Sousa ME (2019) Synthesis, biological evaluation, and in silico studies of novel aminated xanthones as potential p53-activating agents. Molecules 24(10):1975","journal-title":"Molecules"},{"issue":"1","key":"2544_CR16","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s10822-010-9395-8","volume":"25","author":"MA Lill","year":"2010","unstructured":"Lill MA, Danielson ML (2010) Computer-aided drug design platform using PyMOL. J Comput Aided Mol Des 25(1):13\u201319","journal-title":"J Comput Aided Mol Des"},{"key":"2544_CR17","doi-asserted-by":"crossref","first-page":"E626","DOI":"10.3390\/molecules23030626","volume":"23","author":"A Lopes","year":"2018","unstructured":"Lopes A, Martins E, Silva R, Pinto MMM, Remiao F, Sousa E, Fernandes C (2018) Chiral thioxanthones as modulators of p-glycoprotein: synthesis and enantioselectivity studies. Molecules 23:E626","journal-title":"Molecules"},{"issue":"3","key":"2544_CR18","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1124\/mol.58.3.624","volume":"58","author":"C Martin","year":"2000","unstructured":"Martin C, Berridge G, Higgins CF, Mistry P, Charlton P, Callaghan R (2000) Communication between multiple drug binding sites on P-glycoprotein. Mol Pharm 58(3):624\u2013632","journal-title":"Mol Pharm"},{"issue":"4","key":"2544_CR19","doi-asserted-by":"crossref","first-page":"707","DOI":"10.3390\/molecules24040707","volume":"24","author":"E Martins","year":"2019","unstructured":"Martins E, Silva V, Lemos A, Palmeira A, Puthongking P, Sousa E, Rocha-Pereira C, Ghanem CI, Carmo H, Remi\u00e3o F, Silva R (2019) Newly synthesized oxygenated xanthones as potential p-glycoprotein activators: in vitro, ex vivo, and in silico studies. Molecules 24(4):707","journal-title":"Molecules"},{"issue":"7","key":"2544_CR20","doi-asserted-by":"crossref","first-page":"3717","DOI":"10.1021\/cr100446h","volume":"112","author":"KS Masters","year":"2012","unstructured":"Masters KS, Brase S (2012) Xanthones from fungi, lichens, and bacteria: the natural products and their synthesis. Chem Rev 112(7):3717\u20133776","journal-title":"Chem Rev"},{"issue":"1\u20132","key":"2544_CR21","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ijpharm.2009.09.033","volume":"384","author":"P Mitra","year":"2010","unstructured":"Mitra P, Audus KL (2010) MRP isoforms and BCRP mediate sulfate conjugate efflux out of BeWo cells. Int J Pharm 384(1\u20132):15\u201323","journal-title":"Int J Pharm"},{"issue":"2","key":"2544_CR22","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.bbrc.2012.01.155","volume":"419","author":"T Mizutani","year":"2012","unstructured":"Mizutani T, Nakamura T, Morikawa R, Fukuda M, Mochizuki W, Yamauchi Y, Nozaki K, Yui S, Nemoto Y, Nagaishi T, Okamoto R, Tsuchiya K, Watanabe M (2012) Real-time analysis of P-glycoprotein-mediated drug transport across primary intestinal epithelium three-dimensionally cultured in vitro. Biochem Biophys Res Commun 419(2):238\u2013243","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"2544_CR23","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.ctrv.2008.09.004","volume":"35","author":"RL Oostendorp","year":"2009","unstructured":"Oostendorp RL, Beijnen JH, Schellens JH (2009) The biological and clinical role of drug transporters at the intestinal barrier. Cancer Treat Rev 35(2):137\u2013147","journal-title":"Cancer Treat Rev"},{"issue":"12","key":"2544_CR24","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1124\/dmd.31.12.1507","volume":"31","author":"KS Pang","year":"2003","unstructured":"Pang KS (2003) Modeling of intestinal drug absorption: roles of transporters and metabolic enzymes (for the Gillette Review Series). Drug Metab Dispos 31(12):1507\u20131519","journal-title":"Drug Metab Dispos"},{"issue":"7","key":"2544_CR25","first-page":"1886","volume":"52","author":"WHM Peters","year":"1992","unstructured":"Peters WHM, Roelofs HMJ (1992) Biochemical characterization of resistance to mitoxantrone and adriamycin in Caco-2 human colon adenocarcinoma cells: a possible role for glutathione S-transferases. Cancer Res 52(7):1886","journal-title":"Cancer Res"},{"issue":"21","key":"2544_CR26","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.2174\/092986705774370691","volume":"12","author":"MM Pinto","year":"2005","unstructured":"Pinto MM, Sousa ME, Nascimento MS (2005) Xanthone derivatives: new insights in biological activities. Curr Med Chem 12(21):2517\u20132538","journal-title":"Curr Med Chem"},{"issue":"7","key":"2544_CR27","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1038\/nprot.2008.75","volume":"3","author":"G Repetto","year":"2008","unstructured":"Repetto G, del Peso A, Zurita JL (2008) Neutral red uptake assay for the estimation of cell viability\/cytotoxicity. Nat Protoc 3(7):1125\u20131131","journal-title":"Nat Protoc"},{"key":"2544_CR28","doi-asserted-by":"crossref","first-page":"E2617","DOI":"10.3390\/molecules23102617","volume":"23","author":"D Resende","year":"2018","unstructured":"Resende D, Pereira-Terra P, Inacio AS, Costa PMD, Pinto E, Sousa E, Pinto MMM (2018) Lichen xanthones as models for new antifungal agents. Molecules 23:E2617","journal-title":"Molecules"},{"key":"2544_CR29","doi-asserted-by":"crossref","first-page":"114832","DOI":"10.1016\/j.taap.2019.114832","volume":"386","author":"C Rocha-Pereira","year":"2019","unstructured":"Rocha-Pereira C, Ghanem CI, Silva R, Casanova AG, Duarte-Ara\u00fajo M, Gon\u00e7alves-Monteiro S, Sousa E, de Lourdes Bastos M, Remi\u00e3o F (2019) P-glycoprotein activation by 1-(propan-2-ylamino)-4-propoxy-9H-thioxanthen-9-one (TX5) in rat distal ileum: ex vivo and in vivo studies. Toxicol Appl Pharmacol 386:114832","journal-title":"Toxicol Appl Pharmacol"},{"issue":"4","key":"2544_CR30","doi-asserted-by":"crossref","first-page":"2857","DOI":"10.1074\/jbc.M410296200","volume":"280","author":"MF Rosenberg","year":"2005","unstructured":"Rosenberg MF, Callaghan R, Modok S, Higgins CF, Ford RC (2005) Three-dimensional structure of P-glycoprotein: the transmembrane regions adopt an asymmetric configuration in the nucleotide-bound state. J Biol Chem 280(4):2857\u20132862","journal-title":"J Biol Chem"},{"issue":"1","key":"2544_CR31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2174\/1568011043482142","volume":"4","author":"AR Safa","year":"2004","unstructured":"Safa AR (2004) Identification and characterization of the binding sites of P-glycoprotein for multidrug resistance-related drugs and modulators. Curr Med Chem Anticancer Agents 4(1):1\u201317","journal-title":"Curr Med Chem Anticancer Agents"},{"issue":"5","key":"2544_CR32","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s10822-010-9352-6","volume":"24","author":"D Seeliger","year":"2010","unstructured":"Seeliger D, de Groot BL (2010) Ligand docking and binding site analysis with PyMOL and Autodock\/Vina. J Comput Aided Mol Des 24(5):417\u2013422","journal-title":"J Comput Aided Mol Des"},{"issue":"1","key":"2544_CR33","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1042\/bse0500161","volume":"50","author":"FJ Sharom","year":"2011","unstructured":"Sharom FJ (2011) The P-glycoprotein multidrug transporter. Essays Biochem 50(1):161\u2013178","journal-title":"Essays Biochem"},{"issue":"2","key":"2544_CR34","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1124\/jpet.109.153551","volume":"330","author":"F Shen","year":"2009","unstructured":"Shen F, Bailey BJ, Chu S, Bence AK, Xue X, Erickson P, Safa AR, Beck WT, Erickson LC (2009) Dynamic assessment of mitoxantrone resistance and modulation of multidrug resistance by valspodar (PSC833) in multidrug resistance human cancer cells. J Pharm Exp Ther 330(2):423\u2013429","journal-title":"J Pharm Exp Ther"},{"issue":"4","key":"2544_CR35","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s00204-010-0587-8","volume":"85","author":"R Silva","year":"2011","unstructured":"Silva R, Carmo H, Dinis-Oliveira R, Cordeiro-da-Silva A, Lima SC, Carvalho F, Bastos Mde L, Remiao F (2011) In vitro study of P-glycoprotein induction as an antidotal pathway to prevent cytotoxicity in Caco-2 cells. Arch Toxicol 85(4):315\u2013326","journal-title":"Arch Toxicol"},{"key":"2544_CR36","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.cbi.2014.04.009","volume":"218","author":"R Silva","year":"2014","unstructured":"Silva R, Carmo H, Vilas-Boas V, Barbosa DJ, Palmeira A, Sousa E, Carvalho F, Bastos Mde L, Remiao F (2014a) Colchicine effect on P-glycoprotein expression and activity: in silico and in vitro studies. Chem Biol Interact 218:50\u201362","journal-title":"Chem Biol Interact"},{"issue":"10","key":"2544_CR37","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1007\/s00204-014-1333-4","volume":"89","author":"R Silva","year":"2015","unstructured":"Silva R, Palmeira A, Carmo H, Barbosa DJ, Gameiro M, Gomes A, Paiva AM, Sousa E, Pinto M, Bastos Mde L, Remiao F (2015a) P-glycoprotein induction in Caco-2 cells by newly synthetized thioxanthones prevents paraquat cytotoxicity. Arch Toxicol 89(10):1783\u20131800","journal-title":"Arch Toxicol"},{"issue":"4","key":"2544_CR38","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1007\/s00204-014-1193-y","volume":"88","author":"R Silva","year":"2014","unstructured":"Silva R, Sousa E, Carmo H, Palmeira A, Barbosa DJ, Gameiro M, Pinto M, Bastos Mde L, Remiao F (2014b) Induction and activation of P-glycoprotein by dihydroxylated xanthones protect against the cytotoxicity of the P-glycoprotein substrate paraquat. Arch Toxicol 88(4):937\u2013951","journal-title":"Arch Toxicol"},{"key":"2544_CR39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pharmthera.2014.11.013","volume":"149","author":"R Silva","year":"2015","unstructured":"Silva R, Vilas-Boas V, Carmo H, Dinis-Oliveira RJ, Carvalho F, de Lourdes Bastos M, Remiao F (2015b) Modulation of P-glycoprotein efflux pump: induction and activation as a therapeutic strategy. Pharm Ther 149:1\u2013123","journal-title":"Pharm Ther"},{"issue":"4","key":"2544_CR40","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1080\/01480540903130658","volume":"32","author":"K Takara","year":"2009","unstructured":"Takara K, Hayashi R, Kokufu M, Yamamoto K, Kitada N, Ohnishi N, Yokoyama T (2009) Effects of nonsteroidal anti-inflammatory drugs on the expression and function of P-glycoprotein\/MDR1 in Caco-2 cells. Drug Chem Toxicol 32(4):332\u2013337","journal-title":"Drug Chem Toxicol"},{"issue":"2","key":"2544_CR41","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","volume":"31","author":"O Trott","year":"2009","unstructured":"Trott O, Olson AJ (2009) AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem 31(2):455\u2013461","journal-title":"J Comput Chem"},{"issue":"9","key":"2544_CR42","doi-asserted-by":"crossref","first-page":"730","DOI":"10.2174\/138920010794328850","volume":"11","author":"MV Varma","year":"2010","unstructured":"Varma MV, Ambler CM, Ullah M, Rotter CJ, Sun H, Litchfield J, Fenner KS, El-Kattan AF (2010) Targeting intestinal transporters for optimizing oral drug absorption. Curr Drug Metab 11(9):730\u2013742","journal-title":"Curr Drug Metab"},{"issue":"11","key":"2544_CR43","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1002\/cyto.a.21135","volume":"79","author":"V Vilas-Boas","year":"2011","unstructured":"Vilas-Boas V, Silva R, Gaio AR, Martins AM, Lima SC, Cordeiro-da-Silva A, de Lourdes Bastos M, Remiao F (2011) P-glycoprotein activity in human Caucasian male lymphocytes does not follow its increased expression during aging. Cytometry Part A 79(11):912\u2013919","journal-title":"Cytometry Part A"},{"issue":"3","key":"2544_CR44","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.toxlet.2013.05.005","volume":"220","author":"V Vilas-Boas","year":"2013","unstructured":"Vilas-Boas V, Silva R, Nunes C, Reis S, Ferreira L, Vieira C, Carvalho F, Bastos MdL, Remi\u00e3o F (2013a) Mechanisms of P-gp inhibition and effects on membrane fluidity of a new rifampicin derivative, 1,8-dibenzoyl-rifampicin. Toxicol Lett 220(3):259\u2013266","journal-title":"Toxicol Lett"},{"issue":"8","key":"2544_CR45","doi-asserted-by":"crossref","first-page":"e74425","DOI":"10.1371\/journal.pone.0074425","volume":"8","author":"V Vilas-Boas","year":"2013","unstructured":"Vilas-Boas V, Silva R, Palmeira A, Sousa E, Ferreira LM, Branco PS, Carvalho F, Bastos Mde L, Remiao F (2013b) Development of novel rifampicin-derived P-glycoprotein activators\/inducers. synthesis, in silico analysis and application in the RBE4 cell model, using paraquat as substrate. PLoS ONE 8(8):e74425","journal-title":"PLoS ONE"}],"container-title":["Medicinal Chemistry Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00044-020-02544-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00044-020-02544-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00044-020-02544-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,4]],"date-time":"2024-08-04T23:06:16Z","timestamp":1722812776000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00044-020-02544-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,29]]},"references-count":45,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["2544"],"URL":"https:\/\/doi.org\/10.1007\/s00044-020-02544-1","relation":{},"ISSN":["1054-2523","1554-8120"],"issn-type":[{"value":"1054-2523","type":"print"},{"value":"1554-8120","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,29]]},"assertion":[{"value":"13 December 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 April 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}